First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome

Kadri Sani; Salifou Ibrahim Alkassoum; Harouna Amadou Mahaman Laouali; Djibo Sayo Adamou; Garba Abdoul Azize; Boureima Karimou; Daou Mamane

doi:doi:10.11648/j.ajnhs.20220303.13

First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome

Kadri Sani, Salifou Ibrahim Alkassoum, Harouna Amadou Mahaman Laouali, Djibo Sayo Adamou, Garba Abdoul Azize, Boureima Karimou, Daou Mamane

Published in American Journal of Nursing and Health Sciences (Volume 3, Issue 3)

Received: 16 July 2022 Accepted: 28 July 2022 Published: 4 August 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: The increasing access of PLHIV to antiretroviral treatment (ART) over the last decade has led to a substantial reduction in patient morbidity and mortality and an increase in the life expectancy of PLHIV. Objective: The aim of this study was to describe the sociodemographic characteristics and treatment outcome of patients living with HIV. Methods: This is a retrospective, descriptive and cross-sectional study carried out from 1 January 2016 to 31 December 2020. Results: of 253 patients 72.33% of the patients were women and 27.66% were men. 60.07% of the patients were married, 14.62% single, 13.43% widowed and 11.85% divorced, 42.68% of whom lived in a monogamous household. 84% of the patients came from the urban area. HIV/HBV and HIV/TB co-infections were 5.53% and 3.95% respectively. Clinically, 41.89% of the patients are at WHO stage II, 48.61% had an undetectable viral load. The average CD4 cells count was 270 with extremes ranging from 0 to 1818, 94.86% of patients. Conclusion: ART treatment is associated to age, gender and low socio-economic status and low level of education. The majority of patients are in treatment success; between WHO stages I and II, under the TDF-3TC-EFV protocol. Fewer rate of patients was in viral therapeutic failure.

Published in	American Journal of Nursing and Health Sciences (Volume 3, Issue 3)
DOI	10.11648/j.ajnhs.20220303.13
Page(s)	62-66
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

ART, PLHIV, Treatment, Outcome, Niger

References

[1]	ONUSIDA 2020. Rapport sur le suivi mondial de la lutte contre le sida [Global AIDS Monitoring] 2021 https://www. unaids.org/fr/resources/
[2]	UNAIDS. Global HIV & AIDS statistics — 2021 fact sheet. https://www. unaids.org/en/resources/fact-sheet.
[3]	Aves T, Tambe J, Siemieniuk RAC, Mbuagbaw L. Antiretroviral resistance testing in HIV-positive people. Cochrane Database of Systematic Reviews 2018, Issue 11.
[4]	ONUSIDA. 90-90-90 Une cible ambitieuse de traitement pour aider à mettre fin à l’épidémie du sida [An Ambitious treatment to help end the AIDS epidemic], ONUSIDA / JC2684F; 2014.
[5]	Pierre Aubry, Dr Bernard-Alex Gaüzère. Infection par le VIH/Sida et tropiques [HIV/AIDS infections and the topics], Médecine Tropicale, Actualités 2020.
[6]	Thome et al, Échec Thérapeutique, Résistance Acquise du VIH et Souches Virales chez les Adultes sous Traitement Antirétroviral de Deuxième Ligne au Cameroun: Étude sur 18 ans (19992017) de Monitorage à l’Hôpital Central de Yaoundé [Profile of HIV Drug resistance and viral strains among Cameroonian patients receiving a second-line ART: an 18 year study], Health Sci. Dis: Vol 20 (3) May – June 2019.
[7]	Ù^mpmYihienew Mequanint Bezabih, Fekadu Beyene and Woldesellassie M. Bezabhe. Factors associated with first-line antiretroviral treatment failure in adult HIV positive patients: a case-control study from Ethiopia, BMC Infectious Diseases (2019) 19: 537 https://doi.org/10.1186/s12879-019-4170-5
[8]	Diriba Mulisa, Mulugeta Tesfa, Getachew Mullu Kassa and Tadesse Tolossa. Determinants of first line antiretroviral therapy treatment failure among adult patients on ART at central Ethiopia: un-matched case control study, BMC Infectious Diseases (2019) 19: 1024 https://doi.org/10.1186/s12879-019-4651-6
[9]	Muluneh Alene, Tadesse Awoke, Melaku Kindie Yenit and Adino Tesfahun Tsegaye. Incidence and predictors of second-line antiretroviral treatment failure among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study, Infectious Diseases (2019) 19: 599 https://doi.org/10.1186/s12879-019-4243-5
[10]	Caroline Gahrton, Gabriel Westman, Karin Lindah, Fredrik Öhrn, Olav Dalgard, Christer Lidman, Lars-Håkan Nilsson, Karouk Said, Ann-Sofi Duberg and Soo Aleman. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County, BMC Infectious Diseases (2019) 19: 955 https://doi.org/10.1186/s12879-019-4581-3
[11]	Gelila Solomon Haile and Alemseged Beyene Berha. Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia, BMC Pediatrics (2019) 19: 37 https://doi.org/10.1186/s12887-019-1402-1.
[12]	Aklilu Endalamaw, Mengistu Mekonnen, Demeke Geremew, Fikadu Ambaw Yehualashet, Hiwot Tesera and Tesfa Dejenie Habtewold. HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis; BMC Public Health (2020) 20: 82 https://doi.org/10.1186/s12889-020-8160-8.
[13]	Lynne Swarts, Sa’ad Lahri, Dani¨el J. van Hoving. The burden of HIV and tuberculosis on the resuscitation area of an urban district-level hospital in Cape Town African Journal of Emergency Medicine 11 (2021) 165–170 166 https://doi.org/10.1016/j.afjem.2020.09.016.
[14]	Antoine Jaquet, Gilles Wandeler, Judicaël Tine, Claver A. Dagnra, Alain Attia, Akouda Patassi, Abdoulaye Ndiaye, Victor de Ledinghen, Didier K. Ekouevi, Moussa Seydi and François Dabis. HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa. BMC Infectious Diseases (2016) 16: 249 DOI 10.1186/s12879-016-1601-4.
[15]	Kyaw NTT, Harries AD, Kumar AMV, Oo MM, Kyaw KWY, Win T, et al. (2017) High rate of virological failure and low rate of switching to second-line treatment among adolescents and adults living with HIV on first-line ART in Myanmar, 2005-2015. PLoS ONE 12 (2): e0171780. doi: 10.1371/journal.pone.0171780.
[16]	Yihun BA, Kibret GD, Leshargie CT (2019) Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study. PLoS ONE 14 (5): e0215300. https://doi.org/10.1371/journal. pone.0215300
[17]	Carnimeo et al. High level of HIV drug resistance informs dolutegravir roll-out and optimized NRTI backbone strategy in Mozambique, JAC Antimicrob Resist.
[18]	Shrouﬁ A, Van Cutsem G, Cambiano V et al. Simplifying switch to second line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to deﬁne efavirenz-based ﬁrst-line failure. AIDS 2019; 33: 1635–44. 3.
[19]	Boender TS, Kityo CM, Boerma RS et al. Accumulation of HIV-1drug resistance after continued virological failure on ﬁrst-line ART in adults and children in sub-Saharan Africa. J Antimicrob Chemother 2016; 71: 2918–27. 4.
[20]	Roberts T, Cohn J, Bonner K et al. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis 2016; 62: 1043–8.
[21]	Ehrenkranz PD, Baptiste SL, Bygrave H et al. The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings. PLoSMed 2019; 16: e1002820.
[22]	Inzaule SC, Ondoa P, Peter T et al. Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa. Lancet Infect Dis 2016; 16: e267–75.

Cite This Article

Plain Text BibTeX RIS

APA Style

Kadri Sani, Salifou Ibrahim Alkassoum, Harouna Amadou Mahaman Laouali, Djibo Sayo Adamou, Garba Abdoul Azize, et al. (2022). First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome. American Journal of Nursing and Health Sciences, 3(3), 62-66. https://doi.org/10.11648/j.ajnhs.20220303.13

Copy | Download

ACS Style

Kadri Sani; Salifou Ibrahim Alkassoum; Harouna Amadou Mahaman Laouali; Djibo Sayo Adamou; Garba Abdoul Azize, et al. First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome. Am. J. Nurs. Health Sci. 2022, 3(3), 62-66. doi: 10.11648/j.ajnhs.20220303.13

Copy | Download

AMA Style

Kadri Sani, Salifou Ibrahim Alkassoum, Harouna Amadou Mahaman Laouali, Djibo Sayo Adamou, Garba Abdoul Azize, et al. First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome. Am J Nurs Health Sci. 2022;3(3):62-66. doi: 10.11648/j.ajnhs.20220303.13

Copy | Download

@article{10.11648/j.ajnhs.20220303.13,
  author = {Kadri Sani and Salifou Ibrahim Alkassoum and Harouna Amadou Mahaman Laouali and Djibo Sayo Adamou and Garba Abdoul Azize and Boureima Karimou and Daou Mamane},
  title = {First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome},
  journal = {American Journal of Nursing and Health Sciences},
  volume = {3},
  number = {3},
  pages = {62-66},
  doi = {10.11648/j.ajnhs.20220303.13},
  url = {https://doi.org/10.11648/j.ajnhs.20220303.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajnhs.20220303.13},
  abstract = {Background: The increasing access of PLHIV to antiretroviral treatment (ART) over the last decade has led to a substantial reduction in patient morbidity and mortality and an increase in the life expectancy of PLHIV. Objective: The aim of this study was to describe the sociodemographic characteristics and treatment outcome of patients living with HIV. Methods: This is a retrospective, descriptive and cross-sectional study carried out from 1 January 2016 to 31 December 2020. Results: of 253 patients 72.33% of the patients were women and 27.66% were men. 60.07% of the patients were married, 14.62% single, 13.43% widowed and 11.85% divorced, 42.68% of whom lived in a monogamous household. 84% of the patients came from the urban area. HIV/HBV and HIV/TB co-infections were 5.53% and 3.95% respectively. Clinically, 41.89% of the patients are at WHO stage II, 48.61% had an undetectable viral load. The average CD4 cells count was 270 with extremes ranging from 0 to 1818, 94.86% of patients. Conclusion: ART treatment is associated to age, gender and low socio-economic status and low level of education. The majority of patients are in treatment success; between WHO stages I and II, under the TDF-3TC-EFV protocol. Fewer rate of patients was in viral therapeutic failure.},
 year = {2022}
}

Copy | Download

TY - JOUR
T1 - First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome
AU - Kadri Sani
AU - Salifou Ibrahim Alkassoum
AU - Harouna Amadou Mahaman Laouali
AU - Djibo Sayo Adamou
AU - Garba Abdoul Azize
AU - Boureima Karimou
AU - Daou Mamane
Y1 - 2022/08/04
PY - 2022
N1 - https://doi.org/10.11648/j.ajnhs.20220303.13
DO - 10.11648/j.ajnhs.20220303.13
T2 - American Journal of Nursing and Health Sciences
JF - American Journal of Nursing and Health Sciences
JO - American Journal of Nursing and Health Sciences
SP - 62
EP - 66
PB - Science Publishing Group
SN - 2994-7227
UR - https://doi.org/10.11648/j.ajnhs.20220303.13
AB - Background: The increasing access of PLHIV to antiretroviral treatment (ART) over the last decade has led to a substantial reduction in patient morbidity and mortality and an increase in the life expectancy of PLHIV. Objective: The aim of this study was to describe the sociodemographic characteristics and treatment outcome of patients living with HIV. Methods: This is a retrospective, descriptive and cross-sectional study carried out from 1 January 2016 to 31 December 2020. Results: of 253 patients 72.33% of the patients were women and 27.66% were men. 60.07% of the patients were married, 14.62% single, 13.43% widowed and 11.85% divorced, 42.68% of whom lived in a monogamous household. 84% of the patients came from the urban area. HIV/HBV and HIV/TB co-infections were 5.53% and 3.95% respectively. Clinically, 41.89% of the patients are at WHO stage II, 48.61% had an undetectable viral load. The average CD4 cells count was 270 with extremes ranging from 0 to 1818, 94.86% of patients. Conclusion: ART treatment is associated to age, gender and low socio-economic status and low level of education. The majority of patients are in treatment success; between WHO stages I and II, under the TDF-3TC-EFV protocol. Fewer rate of patients was in viral therapeutic failure.
VL - 3
IS - 3
ER -

Copy | Download

Author Information

Kadri Sani

Internal Medicine Department, Regional Hospital Centre, Niamey, Niger
Salifou Ibrahim Alkassoum

Niger Internal Medicine Department, Faculty of Health Sciences, Abdou Moumouni University, Niamey, Niger
Harouna Amadou Mahaman Laouali

Internal Medicine Department, Faculty of Health Sciences, Dan Dicko Dan Koulodo University, Maradi, Niger
Djibo Sayo Adamou

Epidemiology Department, Ba Boubacar University, Tillabery, Niger
Garba Abdoul Azize

Internal Medicine Department, Faculty of Health Sciences, Andre Salifou University, Zinder, Niger
Boureima Karimou

Epidemiology Department, Ba Boubacar University, Tillabery, Niger
Daou Mamane

Niger Internal Medicine Department, Faculty of Health Sciences, Abdou Moumouni University, Niamey, Niger

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Kadri Sani, Salifou Ibrahim Alkassoum, Harouna Amadou Mahaman Laouali, Djibo Sayo Adamou, Garba Abdoul Azize, et al. (2022). First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome. American Journal of Nursing and Health Sciences, 3(3), 62-66. https://doi.org/10.11648/j.ajnhs.20220303.13

Copy | Download

ACS Style

Kadri Sani; Salifou Ibrahim Alkassoum; Harouna Amadou Mahaman Laouali; Djibo Sayo Adamou; Garba Abdoul Azize, et al. First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome. Am. J. Nurs. Health Sci. 2022, 3(3), 62-66. doi: 10.11648/j.ajnhs.20220303.13

Copy | Download

AMA Style

Kadri Sani, Salifou Ibrahim Alkassoum, Harouna Amadou Mahaman Laouali, Djibo Sayo Adamou, Garba Abdoul Azize, et al. First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome. Am J Nurs Health Sci. 2022;3(3):62-66. doi: 10.11648/j.ajnhs.20220303.13

Copy | Download

@article{10.11648/j.ajnhs.20220303.13,
  author = {Kadri Sani and Salifou Ibrahim Alkassoum and Harouna Amadou Mahaman Laouali and Djibo Sayo Adamou and Garba Abdoul Azize and Boureima Karimou and Daou Mamane},
  title = {First Line Antiretroviral Therapy (ART) in Regional Hospital of Niamey (Niger): Socio-demographic Characteristics and Treatment Outcome},
  journal = {American Journal of Nursing and Health Sciences},
  volume = {3},
  number = {3},
  pages = {62-66},
  doi = {10.11648/j.ajnhs.20220303.13},
  url = {https://doi.org/10.11648/j.ajnhs.20220303.13},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajnhs.20220303.13},
  abstract = {Background: The increasing access of PLHIV to antiretroviral treatment (ART) over the last decade has led to a substantial reduction in patient morbidity and mortality and an increase in the life expectancy of PLHIV. Objective: The aim of this study was to describe the sociodemographic characteristics and treatment outcome of patients living with HIV. Methods: This is a retrospective, descriptive and cross-sectional study carried out from 1 January 2016 to 31 December 2020. Results: of 253 patients 72.33% of the patients were women and 27.66% were men. 60.07% of the patients were married, 14.62% single, 13.43% widowed and 11.85% divorced, 42.68% of whom lived in a monogamous household. 84% of the patients came from the urban area. HIV/HBV and HIV/TB co-infections were 5.53% and 3.95% respectively. Clinically, 41.89% of the patients are at WHO stage II, 48.61% had an undetectable viral load. The average CD4 cells count was 270 with extremes ranging from 0 to 1818, 94.86% of patients. Conclusion: ART treatment is associated to age, gender and low socio-economic status and low level of education. The majority of patients are in treatment success; between WHO stages I and II, under the TDF-3TC-EFV protocol. Fewer rate of patients was in viral therapeutic failure.},
 year = {2022}
}

Copy | Download